SCHEMBL30007739

SCHEMBL30007739

CCN(CC)c1ccc(CNC(=O)c2cc3cc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 16/20 0.43
CYP2C9 P11712 3/20 0.43
CNR1 P21554 2/20 0.42
ATR Q13535 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30007878 0.87 NAMPT (0.48) NAMPTCYP2C9ATR
SCHEMBL30007248 0.82 ATR (0.40) NAMPTATR
SCHEMBL30008206 0.82 CLK1 (0.43) NAMPTCYP2C9ATR
Hydrochloric Acid SCHEMBL30007950 0.76 ATR (0.41) ATR
SCHEMBL30007683 0.72 CYP2C9 (0.48) NAMPTCYP2C9
SCHEMBL30007668 0.71 CNR2 (0.37) CNR1ATR
SCHEMBL30007677 0.69 AXL (0.50) NAMPT
SCHEMBL30007830 0.69 DYRK1A (0.45) NAMPTATR
SCHEMBL14575170 0.67 ATR (0.46) NAMPTCYP2C9ATR
SCHEMBL30008202 0.67 KMT2A (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO claimed
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO disclosed